MTERF3 and neoplasm: Additionally, MTERF3 expression was positively correlated with tumor stemness (Figure 8G) and tumor mutation burden (TMB, Figure 8H), as well as the imputed sensitivity of doramapimod (Figure 8I) in the TCGA-LUAD dataset.